David W. Gryska

Executive Vice President and Chief Financial Officer at Incyte Corporation

Are you David W. Gryska? Claim your profile
 
  • IDENTIFY corporate executives in David W. Gryska's network and community.
  • FOLLOW changes in David W. Gryska's employment and money-in-motion.
  • CONNECT with David W. Gryska through your network of contacts.

David W. Gryska's Executive Work History


Current
Executive Vice President and Chief Financial Officer, Incyte Corporation
Board Member, Seattle Genetics, Inc.
Board Member, PDL BioPharma, Inc.
Past
To view David W. Gryska's complete executive work history,
Age
61
 
 

David W. Gryska's Biography


David W. Gryska, age 61, was first appointed a director of the Company in March 2014. Since October 2014, Mr. Gryska has been the Vice President and Chief Financial Officer of Incyte Corporation. He served as Chief Operating Officer and a director of Myrexis, Inc., a biotechnology company, from May 2012 to December 2012. From December 2006 to October 2010, he served as Senior Vice President and Chief Financial Officer of Celgene Corporation, a biopharmaceutical company. From October 2004 to December 2006, he was a principal at Strategic Consulting Group, where he provided strategic consulting to early-stage biotechnology companies. Previously ...

(Read More)

Source: PDL BioPharma, Inc. on 02/14/2017

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like David W. Gryska. More specifically, you'll be able to:

  • IDENTIFY corporate executives in David W. Gryska's network and community.
  • FOLLOW changes in David W. Gryska's employment and money-in-motion.
  • CONNECT with David W. Gryska through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: David W. Gryska

David W. Gryska's Connections (151)


Chief Operating Officer, Seattle Genetics, Inc.
Chairman, President and Chief Executive Officer, Madrigal Pharmaceuticals, Inc.
Lead Independent Director, Celgene Corporation
Dir. and Chief Executive Officer, AcelRx Pharmaceuticals, Inc.
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.